Literature DB >> 26663426

Cardiovascular risk assessment in oncological clinical trials: is there a role for centralized events adjudication?

Muthiah Vaduganathan1, Vinay Prasad2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26663426     DOI： 10.1002/ejhf.457

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  5 in total

1.  Foreword.

Authors:  Andrew Js Coats; Giuseppe Rosano
Journal:  Card Fail Rev       Date:  2017-11

2.  Epirubicin and long-term heart failure risk in breast cancer survivors.

Authors:  Syed S Mahmood; Ravi B Patel; Javed Butler; Muthiah Vaduganathan
Journal:  Eur J Heart Fail       Date:  2018-07-04       Impact factor: 15.534

3.  Efficacy of Neurohormonal Therapies in Preventing Cardiotoxicity in Patients with Cancer Undergoing Chemotherapy.

Authors:  Muthiah Vaduganathan; Sameer A Hirji; Arman Qamar; Navkaranbir Bajaj; Ankur Gupta; Vlad Zaha; Alvin Chandra; Mark Haykowsky; Bonnie Ky; Javid Moslehi; Anju Nohria; Javed Butler; Ambarish Pandey
Journal:  JACC CardioOncol       Date:  2019-09-24

Review 4.  Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection.

Authors:  Marco Bruno Morelli; Chiara Bongiovanni; Silvia Da Pra; Carmen Miano; Francesca Sacchi; Mattia Lauriola; Gabriele D'Uva
Journal:  Front Cardiovasc Med       Date:  2022-04-15

Review 5.  Modern-day cardio-oncology: a report from the 'Heart Failure and World Congress on Acute Heart Failure 2018'.

Authors:  Markus S Anker; Alessia Lena; Sara Hadzibegovic; Yury Belenkov; Jutta Bergler-Klein; Rudolf A de Boer; Alain Cohen-Solal; Dimitrios Farmakis; Stephan von Haehling; Teresa López-Fernández; Radek Pudil; Thomas Suter; Carlo G Tocchetti; Alexander R Lyon
Journal:  ESC Heart Fail       Date:  2018-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.